肺动脉高压2013:分类与治疗的新趋势
被引量:13
摘要
2013年2月,在法国尼斯召开了第五届世界肺高血压论坛。在这次大会上,肺动脉高压(PAH)的临床分类和治疗有诸多变化,现介绍如下。
出处
《中华内科杂志》
CAS
CSCD
北大核心
2013年第8期640-643,共4页
Chinese Journal of Internal Medicine
参考文献9
-
1Parent F, Bachir D, Inamo J, et al. A hemodynamic study ofpulmonary hypertension in sickle cell disease. N Engl J Med,2011 , 365:44-53.
-
2Mehari A, Gladwin MT, Tian X,et al. Mortality in adults withsickle cell disease and pulmonary hypertension. JAMA, 2012,307:I254-1256.
-
3Mehari A, Alam S, Tian X,et al. Hemodynamic predictors ofmortality in adults with sickle cell disease. Am J Respir Crit CareMed, 2013’ 187:840-847.
-
4Sitbon 0, Morrell N. Pathways in pulmonary arterialhypertension:ihe future is here. Eur Respir Rev, 2012,21 :321-327.
-
5Ghofrani HA, Hoeper MM, Halank M, et al. Riociguat forchronic thromboembolic pulmonary hypertension and pulmonaryarterial hypertension : a phase II study. Eur Respir J,2010, 36:792-799.
-
6Hoeper MM, Barst HJ, Bourge RC, et al. Imatinib mesylate asadd-on therapy lor pulmonary arterial hypertension : results of therandomized IMPRES study. Circulation,2013 , 127 : 1128-1138.
-
7Tapson VF, Jing ZC, Xu KF, et al. Oral treprostinil for thetreatment of pulmonary arterial hypertension in patients onbackground endothelin receptor antagonist and/ orphosphodiesterase type 5 inhibitor therapy (thefreedom-c2 study):a randomized controlled trial. Chest, 2013 May 9. [ Epub aheadof print].
-
8Jing ZC, Parikh K, Pulido T, et al. Efficacy and safety of oraltreprostinilmonotherapy for the treatment of pulmonary arterialhypertension : A randomized, controlled trial. Circulation, 2013 ,127:624-633.
-
9Ishikura K, Yamada N, Ito M, et al. Beneficial acute effects ofrho-kinase inhibitor in patients with pulmonary arterialhypertension. Circ J,2006,70: 174-178.
同被引文献138
-
1荆志成.2010年中国肺高血压诊治指南[J].中国医学前沿杂志(电子版),2011,3(2):62-81. 被引量:117
-
2无.肺动脉高压筛查诊断与治疗专家共识[J].中华心血管病杂志,2007,35(11):979-987. 被引量:273
-
3Warnes C A, Williams R G, Bashore T M, et al. AUG/ AHA 2008 Guidelines for the Management of Adults with Congenital Heart Disease: a report of the American Col- lege of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to devel- op guidelines on the management of adults with congenital heart disease) [ J]. Circulation, 2008,118 (23) : e714- e833.
-
4Galie N, Hoeper M M, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmo- nary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) , endorsed by the International Society of Heart and Lung Transplantation (ISHLT) [ J ]. Eur Heart J, 2009, 30 ( 20 ) : 2493-2537.
-
5Badesch D B, Abman S H, Simonneau G, et al. Medical therapy for pulmonary arterial hypertension : updated AC- CP evidence-based clinical practice guidelines [ J ]. Chest, 2007,131 (6) :1917-1928.
-
6Bilkis A A, Alwi M, Hasri S, et al. The Amplatzer duct occluder: experience in 209 patients[ J]. J Am Coil Car- diol, 2001,37 ( 1 ) :258-261.
-
7Lopes A A, O%eary P W. Measurement, interpretation and use of haemodynamic parameters in pulmonary hyper- tension associated with congenital cardiac disease [ J ]. Cardiol Young, 2009,19(5 ) :431-435.
-
8Silversides C K, Dore A, Poirier N, et al. Canadian Car- diovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease : shuntlesions [ J ]. Can J Cardiol, 2010,26 ( 3 ) : e70-e79.
-
9Dimopoulos K, Peset A, Gatzoulis M A. Evaluating oper- ability in adults with congenital heart disease and the role of pretreatment with targeted pulmonary arterial hyperten- sion therapy [ J ]. Int J Cardiol, 2008,129 (2) : 163-171.
-
10Frescura C, Thiene G, Giulia Gagliardi M, et al. Is lung biopsy useful for surgical decision making in congenital heart disease? [ J]. Eur J Cardiothorac Surg, 1991 , 5 (3) :118-122.
引证文献13
-
1卢蓉,张刚成,尚小珂,沈群山,周红梅,刘洋.靶向药物联合介入封堵治疗动脉导管未闭合并艾森门格综合征5例效果观察[J].解放军医药杂志,2014,26(6):12-16. 被引量:4
-
2段林立,陈泳华,张挪富,苏小芬,李时悦,顾莹莹,刘春丽.以肺动脉高压为首要表现慢性骨髓增生性肿瘤1例报告并文献复习[J].中国实用内科杂志,2015,35(4):376-378.
-
3张颖,靳春妍,刘红艳,周辉,宁洁.法舒地尔治疗肺动脉高压疗效的Meta分析[J].现代药物与临床,2015,30(6):726-731. 被引量:4
-
4杨强凤,戴海龙,尹小龙.ACE2-Ang(1-7)-Mas轴与心血管疾病的研究进展[J].中国心血管病研究,2016,14(4):293-296. 被引量:7
-
5白蓉蓉.法舒地尔治疗肺动脉高压患者的研究进展[J].医疗装备,2016,29(24):198-199.
-
6张云云,许凡,褚明,毕立清.老年危重症病人肺动脉高压及相关因素分析[J].实用老年医学,2017,31(6):525-528.
-
7马美玲,刘文东,王芳.肺动脉高压药物的临床应用及市场现状[J].中国新药杂志,2017,26(19):2245-2250. 被引量:6
-
8张湘,张学铭,王赛华,罗俊,尚东亚,吕清,郭美姿,赵志宏,郑昌柱,沈节艳.法舒地尔治疗老年左心室射血分数保留的心力衰竭相关性肺动脉高压的研究[J].临床内科杂志,2017,34(12):837-840. 被引量:6
-
9王涛,谢艳丽.儿童肺高压诊治进展[J].中华小儿外科杂志,2018,39(2):155-159. 被引量:1
-
10尚小珂,董念国,张长东,陈澍,李飞,刘义华,卢蓉,柳梅.新型室间隔缺损临时关闭器封堵巨大室间隔缺损首例报道[J].中华心血管病杂志,2018,46(8):647-649. 被引量:1
二级引证文献53
-
1陈延菲,李斌.小儿肺动脉高压靶向治疗的临床进展[J].心理月刊,2019,0(23):239-240.
-
2卢辉,迪力热巴·肉孜,茶春喜.沙库巴曲缬沙坦在治疗心梗后心衰并发肺动脉高压患者的临床疗效研究[J].兵团医学,2022(3):21-23.
-
3郑植,唐晶晶,彭媛.超声右心功能指标及B型脑钠肽在小儿心脏病合并肺动脉高压临床诊断中的应用价值[J].中国医药,2019,14(1):29-32. 被引量:5
-
4尚小珂,肖书娜,周红梅,Liang ZHONG,丁珊珊,柳梅,张刚成.肺动脉高压与心律失常[J].中华实用诊断与治疗杂志,2015,29(1):1-4. 被引量:8
-
5陈小军,邢银花,陈其章,王红娟.法舒地尔对肺动脉高压血管重塑中ROCK及ET-1活性的影响[J].中国实用医药,2016,11(21):224-225.
-
6杨勇,高峰,尤斌,刘楠,侯晓彤.微创手术治疗先天性心脏病的早期临床效果分析[J].中国医药,2016,11(10):1451-1454. 被引量:6
-
7张妙林,章慧慧,袁红,孙金栋.心脏超声预判慢性左心疾病相关性肺动脉高压患者临床疗效及近期预后[J].中国心血管杂志,2016,21(5):384-387. 被引量:8
-
8梁英会,康大伟,王淼,贝雪艳,李秀华.左心衰竭合并肺动脉高压患者血浆Gal-3水平变化及意义[J].山东医药,2017,57(21):67-69. 被引量:5
-
9张湘,张学铭,王赛华,罗俊,尚东亚,吕清,郭美姿,赵志宏,郑昌柱,沈节艳.法舒地尔治疗老年左心室射血分数保留的心力衰竭相关性肺动脉高压的研究[J].临床内科杂志,2017,34(12):837-840. 被引量:6
-
10李骞,叶伟祥,张强.西地那非治疗老年慢性心力衰竭并发肺动脉高压的效果[J].心脏杂志,2018,30(2):185-188. 被引量:7
-
1蒋鑫,荆志成.肺动脉高压2013:分类与治疗的新趋势[J].浙江医学,2013,35(19):1711-1714. 被引量:1
-
2杨岫岩.系统性血管炎的临床分类与治疗要点[J].新医学,1998,29(3):160-161. 被引量:7
-
3于朝霞.高血压的分类与治疗进展[J].医学综述,2002,8(12):697-698. 被引量:1
-
4张海澄.心房颤动的分类与治疗应当规范化[J].新医学,2005,36(9):554-555. 被引量:3
-
5范彩霞,苗春阳.心房颤动的分类与治疗[J].中国现代药物应用,2013,7(9):84-85.
-
6蒋贵敏.中西医对感冒的分类与治疗[J].药物与人,2014,27(01S):130-130.
-
7辛毅,杨志明,邱戈,胡帮洪,杨波,乐中义,柴祥,高敏.肠梗阻的常见病因分类与治疗策略[J].今日健康,2015,14(8):34-34.
-
8谢万木,王辰.肺动脉高压的定义分类与治疗探讨[J].中国实用内科杂志,2010,30(4):295-298. 被引量:7
-
9吕云福.肠梗阻的常见病因分类与治疗策略[J].中华普外科手术学杂志(电子版),2011,5(3):4-6. 被引量:53
-
10王妮娜,周道明,赵琳.体表良性肿瘤临床分类与治疗进展[J].中国疗养医学,2014,23(1):18-20.